Element Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Element Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$66.76 - $93.49 $3.7 Million - $5.18 Million	-55,365 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$84.28 - $118.5 $4.67 Million - $6.56 Million	55,365 New	55,365 $5.04 Million
Q4 2018 Feb 13, 2019	SELL	$94.77 - $215.54 $153,148 - $348,312	-1,616 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $182,424 - $264,272	880 Added 119.57%	1,616 $346,000
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $74,740 - $231,030	736 New	736 $206,000

295

22M

634K

428K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.18B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.